Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 10/20 | 0.78 |
| ▸ | FAAH | O00519 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | CA12 | O43570 | 7/20 | 0.55 |
| ▸ | CA9 | Q16790 | 7/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 3/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23928524 | 0.88 | PTGS2 (0.78) | PTGS2FAAHKCNH2CA12CA9 | |
| SCHEMBL23928490 | 0.87 | PTGS2 (0.77) | PTGS2CA12CA9POLBMEN1 | |
| SCHEMBL23928542 | 0.87 | PTGS2 (0.66) | PTGS2FAAHKCNH2CA12CA9 | |
| SCHEMBL23928584 | 0.86 | PTGS2 (0.76) | PTGS2CA12CA9CA1CA2 | |
| SCHEMBL23928623 | 0.84 | PTGS2 (0.73) | PTGS2FAAHKCNH2CA12CA9 | |
| SCHEMBL9048810 | 0.84 | FAAH (0.63) | PTGS2FAAHKCNH2CA12CA9 | |
| SCHEMBL9048316 | 0.83 | FAAH (0.61) | PTGS2FAAHKCNH2CA12CA9 | |
| SCHEMBL9047622 | 0.82 | FAAH (0.67) | PTGS2FAAHKCNH2CA12CA9 | |
| SCHEMBL9048111 | 0.82 | FAAH (0.60) | PTGS2FAAHKCNH2CA12CA9 | |
| SCHEMBL23928566 | 0.82 | PTGS2 (0.69) | PTGS2FAAHKCNH2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0731796-A1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1996-09-18 | — | — | EP | disclosed |
| WO-1995015318-A1 | 1,3,5-TRISUBSTITUTED PYRAZOLE COMPOUNDS FOR TREATMENT OF INFLAMMATION | G.D. SEARLE & CO. (US) | 1995-06-08 | — | — | WO | disclosed |